Writers urge improvements to C&J bus service, seek voter support and weigh in on President Trump's first two weeks in office.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

Sen. Mike Yakawich's bill to prohibit the state from buying overdose reversal drugs from companies that settled with states ...

Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

Rockville Centre became the first diocese in New York with a confirmed reorganization plan, providing a potential blueprint ...

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic. If the settlement is finalized, it will ...

The first full year of the post-COVID-pandemic era was characterized in the United States by continued economic recovery, persistently high ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

Purdue Pharma and its controlling Sackler family have offered a new settlement to resolve lawsuits over their involvement in the opioid epidemic, raising the payout from the Sacklers to $6 billion.